NEW YORK (GenomeWeb News) - Sequenom yesterday said second-quarter revenue jumped 41 percent as R&D spending climbed 79 percent and net loss grew 23 percent.
 
Total receipts for the three months ended June 30, 2007 rose to $10.2 million from $7.2 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.